Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cholesterol lowering and arrhythmia recurrences after internal defibrillator implantation (CLARIDI).

Trial Profile

Cholesterol lowering and arrhythmia recurrences after internal defibrillator implantation (CLARIDI).

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2009

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Coronary artery disease; Ventricular arrhythmias
  • Focus Therapeutic Use
  • Acronyms CLARIDI
  • Sponsors Pfizer
  • Most Recent Events

    • 15 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top